, which is used for the brand Ozempic and Wegovy, was developed to treat diabetes but has become a popular way to help people lose weight, with multiple celebrities admitting to taking it., attorneys for Jaclyn Bjorklund said she used Ozempic for over a year until starting before taking Mounjaro in July 2023. The 44-year-old woman is suing the makers for both drugs Novo Nordisk and Eli Lilly for failing to warn of the risk of gastroparesis and gastroenteritis.
Bjorklund experienced severe vomiting, gastrointestinal burning and was hospitalized for stomach pain, the suit alleges. Some of her teeth fell out during the excessive vomiting, and she threw up whole foods hours after eating, the document added. The prescribing information for Ozempic states taking the drug comes with the risk of frequent adverse events such as nausea, vomiting, diarrhea, abdominal pain, and constipation. In the section detailing drug interactions, Novo Nordisk notes that Ozempic can possibly slow gastric emptying, which could affect the absorption of oral medications.
“Patient safety is of utmost importance to Novo Nordisk,” a spokesperson for Novo Nordisk told USA TODAY in response to the lawsuit. “We are continuously monitoring the safety profile of our products and collaborate closely with authorities to ensure patient safety, including adequate information on gastrointestinal side effects in the label.”
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Fonte: CNBC - 🏆 12. / 72 Consulte Mais informação »